News - Inspire Medical Systems Faces Securities Fraud Lawsuit Amid Stock Plunge

SAN FRANCISCO, Dec. 27, 2025 — Inspire Medical Systems, Inc. (NYSE: INSP) has become the target of a securities class action lawsuit after its stock price fell by $42.04, reportedly due to undisclosed issues with the launch of their Inspire V device. Hagens Berman, a national investor rights law firm, invites those who bought INSP securities between August 6, 2024, and August 4, 2025, to step forward by the January 5, 2026, deadline to potentially join the lawsuit. The complaint claims that Inspire Medical misled investors about its readiness for the commercial rollout of Inspire V, spotlighting problems with essential Medicare billing software and a surplus of unsold inventory from previous device models. These operational flaws allegedly emerged, leading to a stock price crash after future guidance was downgraded. Hagens Berman’s investigation is examining the gap between Inspire Medical’s reported operational successes and the reality. Lead attorney Reed Kathrein encourages affected investors to consider their legal rights by reaching out to the firm. Moreover, whistleblowers with confidential information are asked to contribute to the investigation and may benefit from rewards under the SEC's Whistleblower program. Hagens Berman is a renowned global litigation firm that specializes in investor rights and corporate accountability, with a proven history in handling multimillion-dollar cases. For further details and updates, investors are urged to visit the firm’s dedicated case webpage.